Antibody kinetics in primary- and secondary-care physicians with mild to moderate SARS-CoV-2 infection.
IgG
SARS-CoV-2
antibody kinetics
primary- and secondary-care physicians
serological testing
Journal
Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
pubmed:
14
7
2020
medline:
5
8
2020
entrez:
14
7
2020
Statut:
ppublish
Résumé
Three hundred and ninety-seven primary- and secondary-care physicians were tested for the presence of IgG (and IgA) antibodies against SARS-coronavirus-2 with a commercially available ELISA. In 19 of 20 individuals with PCR-proven infection and only mild to moderate symptoms not requiring hospitalization positive IgG levels occurred within two to three weeks. Among the remaining 377 persons without clear-cut evidence of infection, unequivocally positive IgG antibodies were found in only one, showing a surprisingly low prevalence (0.3%, 95% CI: 0.01-1.5) in physicians with likely contacts with infected patients in a region highly affected by the pandemic (Tyrol, Austria).
Identifiants
pubmed: 32654611
doi: 10.1080/22221751.2020.1793690
pmc: PMC7473111
doi:
Substances chimiques
Antibodies, Viral
0
Immunoglobulin A
0
Immunoglobulin G
0
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
1692-1694Références
Euro Surveill. 2020 Feb;25(5):
pubmed: 32019636
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Euro Surveill. 2020 Apr;25(16):
pubmed: 32347204
Clin Infect Dis. 2020 Jul 28;71(15):778-785
pubmed: 32198501
Emerg Microbes Infect. 2020 Dec;9(1):833-836
pubmed: 32306864
Emerg Microbes Infect. 2020 Dec;9(1):940-948
pubmed: 32357808
J Infect Dis. 2020 Jul 6;222(3):362-366
pubmed: 32473021
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Clin Infect Dis. 2020 Nov 19;71(16):2255-2258
pubmed: 32337590